Skip to content
EntityQ7678869· pop 8· linked from 502 articles

talampanel

Sign in to save

Also known as GYKI 537773, LY-300164, LY300164

Talampanel (INN; development codes GYKI 537773 and LY300164) is a drug which has been investigated for the treatment of epilepsy, malignant gliomas, and amyotrophic lateral sclerosis (ALS).

Wikidata facts

Mass
337.142641
Show 3 more facts
chemical formula
C₁₉H₁₉N₃O₃
canonical SMILES
CC1CC2=CC3=C(C=C2C(=NN1C(=O)C)C4=CC=C(C=C4)N)OCO3
isomeric SMILES
C[C@@H]1CC2=CC3=C(C=C2C(=NN1C(=O)C)C4=CC=C(C=C4)N)OCO3
Sources (2)

via Wikidata · CC0

~1 min read

Encyclopedic overview

2 sections
Contents
  • See also
  • References

Talampanel (INN; development codes GYKI 537773 and LY300164) is a drug which has been investigated for the treatment of epilepsy, malignant gliomas, and amyotrophic lateral sclerosis (ALS).

As of May 2010, results from the trial for ALS have been found negative. Talampanel is not currently under development.

Excerpted from Wikipedia’s “talampanel” article, available under the CC BY-SA 4.0 licence.

Available in 8 languages

via Wikidata sitelinks · CC0